Streetbeat News

Equity Actions

PANW

Palo Alto Networks' board has authorized an additional $500 million for share repurchases, indicating confidence in the company's financial health and future prospects.

Portfolio Pulse from Benzinga Newsdesk

August 19, 2024 | 8:07 pm

KYMR

Kymera Therapeutics is launching a public offering of $200M in common stock and pre-funded warrants, with an option for underwriters to purchase an additional $30M. The proceeds will support its degrader programs and potential acquisitions.

Portfolio Pulse from Benzinga Newsdesk

August 19, 2024 | 8:02 pm

CREG

Smart Powerr Corp has filed with the SEC for a mixed shelf offering of up to $50 million. This move allows the company to issue various types of securities, which could be used for general corporate purposes, including debt repayment, acquisitions, or capital expenditures.

Portfolio Pulse from Benzinga Newsdesk

August 19, 2024 | 5:52 pm

ALZN

LQDA

NKLA

TOVX

VRAX

Nikola Corporation's shares fell by 10.4% after announcing a securities purchase agreement and a mixed shelf offering. Other stocks like Alzamend Neuro and Virax Biolabs saw significant gains, while Liquidia Corporation and Theriva Biologics experienced notable declines.

Portfolio Pulse from Avi Kapoor

August 19, 2024 | 5:37 pm

FFIE

Faraday Future Intelligent Electric Inc (NASDAQ:FFIE) began trading on a split-adjusted basis following a 1-for-40 reverse stock split. The company also announced a launch event for its China-U.S. Automotive Bridge Strategy, aiming to introduce a mass-market second brand. FFIE shares were down over 21.8% at $4.02.

Portfolio Pulse from Adam Eckert

August 19, 2024 | 4:38 pm

ALZN

CING

LQDA

SOND

TOVX

VRAX

U.S. stocks rose with the Dow Jones, NASDAQ, and S&P 500 all gaining. Alzamend Neuro shares surged 418% due to a new partnership for a PTSD treatment study. Virax Biolabs shares increased 308% following WHO's virus emergency declaration. Sonder Holdings shares rose 46% after a licensing agreement with Marriott. Liquidia Corporation shares fell 39% after FDA's tentative approval of YUTREPIA. Theriva Biologics shares dropped 29% following a reverse stock split. Cingulate shares decreased 33% after increasing its stock offering price.

Portfolio Pulse from Avi Kapoor

August 19, 2024 | 4:28 pm

RITR

Reitar Logtech Holdings Limited is set to begin trading on NASDAQ under the ticker RITR on August 20. The IPO price is expected to be between $4.00 and $5.00 per share, with a 180-day insider lock-up period.

Portfolio Pulse from Benzinga Insights

August 19, 2024 | 3:00 pm

NKLA

Nikola shares declined following the announcement of a securities purchase agreement and a mixed shelf offering filing.

Portfolio Pulse from Benzinga Newsdesk

August 19, 2024 | 2:23 pm

CING

Cingulate's stock is trading lower following the company's decision to increase the maximum offering price for its common stock from $8.47 million to $11.33 million.

Portfolio Pulse from Benzinga Newsdesk

August 19, 2024 | 1:56 pm

CING

Cingulate has increased the maximum offering price for its common stock under its sales agreement from $8.47 million to $11.33 million. The company filed a prospectus supplement for an additional $2.86 million of shares, having already sold shares worth $8.47 million.

Portfolio Pulse from Benzinga Newsdesk

August 19, 2024 | 1:48 pm